Reinventing Drug Discovery

The core of ATM Metabolics’ research is based on the “ADME” process. This drug development approach focuses on Absorption, Distribution, Metabolism and Excretion as the four main cornerstones to creating safer and more effective therapeutics.
Today, diabetes is growing at an ever increasing rate due to the also increasing use of refined sugars, especially in children. ATM Metabolics created EMULIN to combat one of the leading causes of diabetes, hyperglycemia.

EMULIN works by a combinational approach to mitigate the damage cause by hyperglycemia from the diet by its insulinomimetic affects.

EMULIN can:
1.   Reduce the dietary absorption of carbohydrates in the upper G.I.
2.   Reduce Glucose Synthesis in the Liver.
3.   Accelerate Glucose Uptake from the bloodstream.
4.   Mobilize carbohydrates (glucose) from adipocytes.
5.   Increase the sensitivity of Insulin receptors in the signaling pathways. (make insulin more efficient)
To request additional info click here.